These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34757053)

  • 1. European Medical Education Initiative on Noonan syndrome: A clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan syndrome across Europe.
    García-Miñaúr S; Burkitt-Wright E; Verloes A; Shaikh G; Lebl J; Östman-Smith I; Wolf CM; Ortega Castelló E; Tartaglia M; Zenker M; Edouard T
    Eur J Med Genet; 2022 Jan; 65(1):104371. PubMed ID: 34757053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of growth failure and other endocrine aspects in patients with Noonan syndrome across Europe: A sub-analysis of a European clinical practice survey.
    Edouard T; Zenker M; Östman-Smith I; Ortega Castelló E; Wolf CM; Burkitt-Wright E; Verloes A; García-Miñaúr S; Tartaglia M; Shaikh G; Lebl J
    Eur J Med Genet; 2022 Jan; 65(1):104404. PubMed ID: 34896604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cardiac aspects in children with Noonan syndrome - results from a European clinical practice survey among paediatric cardiologists.
    Wolf CM; Zenker M; Burkitt-Wright E; Edouard T; García-Miñaúr S; Lebl J; Shaikh G; Tartaglia M; Verloes A; Östman-Smith I
    Eur J Med Genet; 2022 Jan; 65(1):104372. PubMed ID: 34757052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noonan syndrome: clinical features, diagnosis, and management guidelines.
    Romano AA; Allanson JE; Dahlgren J; Gelb BD; Hall B; Pierpont ME; Roberts AE; Robinson W; Takemoto CM; Noonan JA
    Pediatrics; 2010 Oct; 126(4):746-59. PubMed ID: 20876176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
    Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
    Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Noonan syndrome: genetic and clinical update and treatment options].
    Carcavilla A; Suárez-Ortega L; Rodríguez Sánchez A; Gonzalez-Casado I; Ramón-Krauel M; Labarta JI; Quinteiro Gonzalez S; Riaño Galán I; Ezquieta Zubicaray B; López-Siguero JP
    An Pediatr (Engl Ed); 2020 Jul; 93(1):61.e1-61.e14. PubMed ID: 32493603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.
    Linglart L; Gelb BD
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):73-80. PubMed ID: 32022400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noonan syndrome.
    Roberts AE; Allanson JE; Tartaglia M; Gelb BD
    Lancet; 2013 Jan; 381(9863):333-42. PubMed ID: 23312968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RAS/MAPK signal transduction pathway and its role in the pathogenesis of Noonan syndrome].
    Gos M; Leszkiewicz M; Abramowicz A
    Postepy Biochem; 2012; 58(3):255-64. PubMed ID: 23373411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noonan syndrome - a new survey.
    Tafazoli A; Eshraghi P; Koleti ZK; Abbaszadegan M
    Arch Med Sci; 2017 Feb; 13(1):215-222. PubMed ID: 28144274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
    Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
    Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noonan syndrome: improving recognition and diagnosis.
    Zenker M; Edouard T; Blair JC; Cappa M
    Arch Dis Child; 2022 Dec; 107(12):1073-1078. PubMed ID: 35246453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical practice guidelines for Noonan syndrome].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Li X; Wang X; Wang J; Fu L; Luo X; Fu J; Shen Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):324-328. PubMed ID: 32128752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of primary hyperparathyroidism in Europe.
    Langdahl BL; Ralston SH
    QJM; 2012 Jun; 105(6):519-25. PubMed ID: 22566664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence of the importance of RIT1 in Noonan syndrome.
    Bertola DR; Yamamoto GL; Almeida TF; Buscarilli M; Jorge AA; Malaquias AC; Kim CA; Takahashi VN; Passos-Bueno MR; Pereira AC
    Am J Med Genet A; 2014 Nov; 164A(11):2952-7. PubMed ID: 25124994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal function in Noonan syndrome.
    Edouard T; Cartault A
    Ann Endocrinol (Paris); 2022 Jun; 83(3):203-206. PubMed ID: 35489412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of Noonan syndrome diagnosed in primary healthcare].
    Villaroel-Vargas J; Molina-Vargas L; Zurita-Leal A; Zavala-Calahorrano A
    Medwave; 2020 Feb; 20(2):e7826. PubMed ID: 32119651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
    Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
    J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.